Abate AS Industries Limited has announced the successful launch of its indigenously developed Electronic Medical Record (EMR) System, designed as a comprehensive Eye Hospital Clinic Management System. The announcement was made through a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015, dated February 17, 2026.

System Launch and Implementation

The system was launched through the company's healthcare subsidiary M/s Prudential Management Services Private Limited at Abate EYE Hospital. The comprehensive digital ecosystem is tailored specifically for ophthalmic practice and represents more than standard EMR functionality.

Development and Objectives

Developed through the collective efforts of the company's internal medical, clinical, operational, and technical teams, this digital transformation initiative aims to achieve multiple strategic objectives:

• Enhance data accuracy and clinical documentation standards
• Improve inter-departmental coordination and workflow efficiency
• Enable real-time reporting and centralized management oversight
• Strengthen patient experience through faster and more structured service delivery
• Support scalability across current and future branches

Patient Management Features

The newly implemented system includes an integrated online appointment management module that enables patients to directly select available consultation slots and complete digital payments in advance. The company anticipates that this structured scheduling framework will significantly reduce patient no-show ratios and optimize doctor chair-time utilisation.

Operational Efficiency Benefits

The automation of appointment handling and billing workflows is expected to reduce manual administrative dependency at call center and reception levels. This improvement is anticipated to enhance cost efficiency and contribute positively to operating margins over time, while improving operational planning efficiency.

Strategic Significance

The implementation of this advanced Eye Hospital Clinic Management System marks a significant milestone in the company's digital healthcare journey. The launch reinforces the company's commitment to innovation, operational excellence, and patient-centric care in alignment with its core philosophy of "Advance and Ethical." The system represents a comprehensive approach to digital healthcare management specifically designed for ophthalmic practice requirements.

Abate AS Industries Limited has issued a clarification to BSE Limited regarding the significant movement observed in its share price during recent trading sessions. The response comes following a surveillance inquiry from the stock exchange dated February 04, 2026.

Company's Response to BSE Inquiry

The company received a letter from BSE (Reference No. L/SURV/ONL/PV/AJ/2025-2026/3324) seeking clarification about the notable price movement in its scrip code 531658. In its formal response dated February 05, 2026, Abate AS Industries addressed the exchange's concerns comprehensively.

Regulatory Compliance Confirmation

The company emphasized its adherence to disclosure requirements under SEBI regulations. Abate AS Industries confirmed that it has timely informed BSE of all events and information that could impact its operations and performance. This includes all price-sensitive information as mandated under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key compliance aspects highlighted by the company include:

• Timely disclosure of all material events affecting operations
• Compliance with price-sensitive information requirements
• Adherence to Regulation 30 and other applicable SEBI regulations
• Commitment to ongoing transparency obligations

Market-Driven Price Movement

Abate AS Industries categorically stated that no pending information or announcements from the company could explain the recent price behavior. The management attributed the significant share price movement purely to prevailing market conditions and emphasized that it was entirely market-driven rather than company-specific factors.

Management Statement

Company Secretary and Compliance Officer Heena Kausar Mohd Amin Rangari (ACS: 49820) signed the clarification on behalf of the company. The response reaffirmed the company's commitment to inform stock exchanges of any price-sensitive information as required under regulatory frameworks.

The company assured BSE that it remains prepared to provide any additional clarification or information if required by the exchange. This proactive approach demonstrates the company's commitment to maintaining transparency and regulatory compliance in its market communications.